Stock listing
NASDAQ:AVDL Avadel Pharmaceuticals PLC Stock
Follow Avadel Pharmaceuticals PLC into a list and get an email when it puts out news.
Last close · NASDAQ:AVDL
$21.63 USD
Close on Feb 10, 2026 · No longer trades
- Lowest – highest close
- $0.94 – $42.85 USDSince Jun 7, 1996 · lowest Oct 8, 2001 · highest Sep 19, 2003
Delisted NASDAQ:AVDL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:AVDL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Avadel Pharmaceuticals PLC on 6ix
- Decks
- 28 decks · latest Aug 7, 2025
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2025 Earnings Presentation | Earnings | 25 slides | Aug 7, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 16 slides | May 7, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 16 slides | Jan 8, 2025 |
| Technical Presentation (April 2020) | Technical | 24 slides | Apr 27, 2020 |
| Investor Presentation (January 2020) | Investor deck | 15 slides | Jan 10, 2020 |
| Piper Jaffray Healthcare Conference December 2019 | Conference | 14 slides | Dec 5, 2019 |
| Technical Presentation (September 2019) | Technical | 17 slides | Sep 25, 2019 |
| Investor Presentation (September 2019) | Investor deck | 14 slides | Sep 24, 2019 |
| Q3 2018 Earnings Presentation | Earnings | 10 slides | Nov 5, 2018 |
| Q2 2018 Earnings Presentation | Earnings | 24 slides | Aug 7, 2018 |
All 28 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Susan Rodriguez Other companies: Monopar Therapeutics Inc. (Chief Commercial and Strategy Officer · Since at least Mar 2, 2026); Veradigm Inc. (Director · Since at least Feb 17, 2023); Heron Therapeutics, Inc. (Director · Sep 20, 2021 – Jan 31, 2025 · Past); Ardelyx, Inc. (Chief Commercial Officer · May 18, 2020 – May 21, 2024 · Past) | Chief Operating Officer · Since at least May 13, 2025 |
| Douglas J. Williamson Other companies: Vistagen Therapeutics, Inc. (Director · Since at least Jul 29, 2026); ACADIA Pharmaceuticals Inc. (Executive VP, Research & Dev · Feb 1, 2023 – Feb 10, 2023 · Past) | Chief Medical Officer · Feb 14, 2022 – Feb 14, 2022 · Past |
| Eric J Ende Other companies: Matinas BioPharma Holdings, Inc. (Director · Nov 14, 2022 – Nov 1, 2023 · Past); NeuBase Therapeutics Inc (Director · Sep 9, 2022 – Sep 9, 2022 · Past) | Director · Since at least May 27, 2022 |
| Linda Palczuk Other companies: Verrica Pharmaceuticals Inc. (Chief Operating Officer · Jun 14, 2018 – Feb 28, 2019 · Past); Osiris Therapeutics Inc (President & CEO · Jul 10, 2017 – Jul 10, 2017 · Past) | Director · Since at least Jul 18, 2018 |
| Naseem Amin Other companies: Bellerophon Therapeutics Inc (Director · Jun 29, 2015 – Jun 7, 2023 · Past) | Director · Since at least May 17, 2024 |
| Richard J Kim Other companies: Intercept Pharmaceuticals Inc (President US Comm & Strat Mktg · May 1, 2017 – Dec 31, 2020 · Past) | Chief Commercial Officer · Feb 15, 2021 – Feb 20, 2024 · Past |
| Benoit Van Assche | Director · Jun 28, 2017 – Jul 9, 2018 · Past |
| Gregory J Divis | Chief Executive Officer, Director · Since at least Feb 12, 2026 |
| Marcus W Elrod | VP, Sales · Aug 29, 2016 – Jan 3, 2017 · Past |
| Mark Anthony McCamish | Director · Since at least Jul 29, 2025 |
All 12 people
| Person | Seat |
|---|---|
| Peter J Thornton | Director · Since at least Jun 28, 2017 |
| Phillandas T Thompson | See Remarks · Dec 12, 2017 – Mar 7, 2019 · Past |
Log in to ask 6ix AI your own questions about Avadel Pharmaceuticals PLC.